Insulin Infusion Pumps Market size was estimated at USD 12.2 Bn in 2021, growing at a CAGR of 8.9% during the forecast period 2021-2027. Insulin infusion pumps are the devices which are used to administer insulin in diabetes mellitus patients. Insulin infusion pumps administer the accurate dose of insulin into the body with less pain. Insulin pumps are working as alternative systems for insulin pen and daily insulin injection. Scheduling of mealtime is not required with the using of insulin infusion pumps. Insulin infusion pumps contain a pump, reservoir, tubing system, and disposable infusion set with a cannula for the subcutaneous insertion. These devices reduce the number of insulin daily injections with syringe or pen. Insulin Infusion Pumps Market is growing at a significant CAGR owing to increase in the technological advancements in the insulin devices. Increase in the prevalence of diabetes fuels the growth of insulin pumps market. According to the International Diabetes Federation (IDF), 7 Mn people are added every year to the pool of 246 million diabetics, which is projected to increase approximately 438 Mn by 2030. Patent approvals, product launchings, product approvals, innovation of novel products, and acquisitions are the strategies followed by the companies for strengthening position in the insulin infusion pumps market. For instance, Tandem Diabetes Care, Inc. filled a U.S. patent for the medical infusion pump with remote bolus feature. Moreover, in September 2016, Medtronic Minimed, Inc. received FDA approval for insulin infusion pump 670G system with continuous glucose monitoring system.